- Report
- October 2024
- 83 Pages
Global
From €4302EUR$4,850USD£3,725GBP
- Report
- September 2024
- 118 Pages
Global
From €3991EUR$4,500USD£3,456GBP
- Report
- May 2024
- 40 Pages
Global
From €616EUR$695USD£534GBP
- Report
- January 2024
- 201 Pages
Global
From €3991EUR$4,500USD£3,456GBP
- Report
- October 2023
- 85 Pages
United States
From €4302EUR$4,850USD£3,725GBP
- Report
- August 2023
- 180 Pages
Global
From €3326EUR$3,750USD£2,880GBP
- Report
- July 2023
- 100 Pages
Global
From €4302EUR$4,850USD£3,725GBP
- Drug Pipelines
- April 2023
- 34 Pages
Global
From €8866EUR$9,995USD£7,677GBP
- Report
- September 2022
Global
€4990EUR$6,026USD£4,472GBP
- Report
- September 2022
- 240 Pages
Global
From €4923EUR$5,550USD£4,263GBP
- Report
- June 2022
- 220 Pages
Global
From €3060EUR$3,450USD£2,650GBP
- Report
- November 2020
- 450 Pages
Global
From €4346EUR$4,900USD£3,764GBP
- Report
- September 2020
- 700 Pages
Global
From €4346EUR$4,900USD£3,764GBP
- Drug Pipelines
- July 2020
- 33 Pages
Global
From €3104EUR$3,500USD£2,688GBP
- Drug Pipelines
- February 2020
- 96 Pages
Global
From €3104EUR$3,500USD£2,688GBP
- Drug Pipelines
- January 2020
- 112 Pages
Global
From €3104EUR$3,500USD£2,688GBP
- Report
- August 2019
- 42 Pages
Global
€2657EUR$2,995USD£2,300GBP
- Report
- November 2022
- 71 Pages
Global
From €3104EUR$3,500USD£2,688GBP
- Report
- August 2024
- 84 Pages
Global
From €3500EUR$4,227USD£3,137GBP
- Report
- January 2024
- 174 Pages
Global
From €3500EUR$4,227USD£3,137GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more